We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

88 hedge funds and large institutions have $229M invested in Utah Medical Products in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 32

1.48% less ownership

Funds ownership: 74.76% → 73.28% (-1.5%)

2% less funds holding

Funds holding: 90 → 88 (-2)

13% less capital invested

Capital invested by funds: $263M → $229M (-$33.9M)

15% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 13

Holders
88
Holders Change
-2
Holders Change %
-2.22%
% of All Funds
1.96%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
32
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RHJA
Rice Hall James & Associates
California
+$1.78M
2
Marshall Wace
Marshall Wace
United Kingdom
+$822K
3
BlackRock
BlackRock
New York
+$772K
4
CEP
Chicago Equity Partners
Illinois
+$635K
5
Lazard Asset Management
Lazard Asset Management
New York
+$581K

Top Sellers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
-$1.93M
2
Invesco
Invesco
Georgia
-$1.49M
3
PPA
Parametric Portfolio Associates
Washington
-$1.18M
4
ACM
Ativo Capital Management
Illinois
-$1.13M
5
Russell Investments Group
Russell Investments Group
United Kingdom
-$1.03M
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
76
Federation des caisses Desjardins du Quebec
Quebec, Canada
$18.7K – – –
CCM
77
Copeland Capital Management
Pennsylvania
$17K +$17.5K +199 New
PCM
78
Prelude Capital Management
New York
$13K +$13.8K +157 New
Bank of Montreal
79
Bank of Montreal
Ontario, Canada
$12K +$2.11K +24 +20%
BNP Paribas Financial Markets
80
BNP Paribas Financial Markets
France
$11.3K -$10.5K -119 -47%
Nisa Investment Advisors
81
Nisa Investment Advisors
Missouri
$10K – – –
Barclays
82
Barclays
United Kingdom
$8K -$161K -1,824 -95%
Canada Life
83
Canada Life
Manitoba, Canada
$2K -$1.58K -18 -37%
DA
84
Denali Advisors
California
$2K – – –
Carson Wealth (CWM LLC)
85
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
MAM
86
Meeder Asset Management
Ohio
$1K – – –
S
87
SignatureFD
Georgia
$1K +$176 +2 +20%
PMFA
88
Plante Moran Financial Advisors
Michigan
$1K +$792 +9 New
PPA
89
Parametric Portfolio Associates
Washington
– -$1.18M -12,541 Closed
ACM
90
Ativo Capital Management
Illinois
– -$1.13M -12,025 Closed
SIM
91
Spark Investment Management
New York
– -$471K -5,000 Closed
Millennium Management
92
Millennium Management
New York
– -$396K -4,207 Closed
B
93
Bailard
California
– -$330K -3,500 Closed
HW
94
Hancock Whitney
Mississippi
– -$319K -3,386 Closed
Two Sigma Advisers
95
Two Sigma Advisers
New York
– -$254K -2,700 Closed
Goldman Sachs
96
Goldman Sachs
New York
– -$240K -2,548 Closed
Citadel Advisors
97
Citadel Advisors
Florida
– -$227K -2,411 Closed
SCP
98
Seizert Capital Partners
Michigan
– -$225K -2,387 Closed
SWP
99
Stratos Wealth Partners
Ohio
– -$44K -465 Closed
New York State Teachers Retirement System (NYSTRS)
100
New York State Teachers Retirement System (NYSTRS)
New York
– -$28K -300 Closed
1 2 3
4
5

UTMD Hedge Fund Activity: Q4 2018 in Review

88 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2018, worth a combined $229M — down 13% from $263M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of UTMD and 11 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 32 added.

The largest buyer was Rice Hall James & Associates, adding an estimated $1.78M. The largest seller was Ancora Advisors, cutting an estimated $1.93M.

  • 88 institutional investors held Utah Medical Products (UTMD) as of Q4 2018, down from 90 in Q3 2018.
  • Funds reported $229M of Utah Medical Products stock for Q4 2018, down 13% quarter-over-quarter.
  • 11 funds opened new Utah Medical Products positions in Q4 2018 and 13 closed out, a net change of -2 holders.
  • The largest Utah Medical Products buyer in Q4 2018 was Rice Hall James & Associates, an estimated $1.78M added.
  • The largest Utah Medical Products seller in Q4 2018 was Ancora Advisors, an estimated $1.93M sold.

Based on aggregated 13F filings for Q4 2018.